Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment. Companion diagnostics market is still nascent, and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013, growing at a CAGR of 20% during 2014 to 2020.

1. Global Companion Diagnostic (CD) Market is Expected to Reach $3.5
Billion by 2020

2. Published Date: 03 May 2014
107 Pages
Report
Published Date : 10 June 2014

3. Table of Content
1. Introduction
2. Executive Summary
3. Global 3D Technology Market Overview
4. Global 3D Technology Market by Products
5. Global 3D Technology Market by Applications
6. Global 3D Technology Market by Geography
7. Company Profiles
Introduction
Scope of the Report Key Benefits
Key Audiences

4. Description
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic
responses of patients for a specific treatment. Companion diagnostics market is still nascent,
and it is projected to reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013,
growing at a CAGR of 20% during 2014 to 2020.
The global companion diagnostic market is segmented based on indication, technology and
geography (North America, Europe, Asia Pacific and LAMEA). Geographically, LAMEA is the
fastest growing region. The key drivers for this market are the increase in the discovery of
biomarkers and co-development of drug and corresponding diagnostic.
However, cost associated with developing drugs could impede the growth of this market.
Opportunities for this market lie in developing companion diagnostics for various central
nervous system conditions and hereditary conditions.

5. Assessments are made according to the current business scenario and the future market trends
are forecast for the period 2013-2020, with the base figures of the year 2013
The analysis gives a wider view of the global market including its market trends, market structure,
limiting factors and opportunities for the market
Porter’s five force’s model helps in analyzing the potential of buyers & suppliers, and the
competitive sketch of the market, which would guide the market players to develop strategies
accordingly
The value chain analysis provides a systematic study on the key intermediaries involved, which
would in turn help the stakeholders in the market to make appropriate strategies
The advantages of the market are analyzed to help the stakeholders identify the opportunistic
areas in a comprehensive manner
KEY BENEFITS

6. Companion Diagnostic Technologies Market Analysis
Companion Diagnostics Indication Market Analysis
Companion diagnostics is segmented on the basis of its use for indications such as oncology,
cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology
is the highest revenue generating segment, as majority of the companion diagnostics have been
developed for detection of various cancer biomarkers.
Companion Diagnostics Technology Market Analysis
Companion diagnostics technology market is segmented into Immunohistochemistry and Molecular
diagnostics. Molecular diagnostics would be the fastest growing and highest revenue generator,
mainly due to the use of techniques such as real time PCR, In Situ Hybridization and next
generation sequencing. Other factors contributing to the growth is technological advancements in
molecular diagnostics, which has resulted in increased accuracy and precision and also reduced
cost of testing using these methods.
Companion Diagnostics Geography Market Analysis
Companion Diagnostics market has been segmented geographically into North America, Europe,
Asia Pacific and LAMEA. North America has the major market share of 43.97% followed by Europe,
which accounted for about 38% of the overall CD market in 2013. North America and Europe
together accounted for over 82% in the global CD market in 2013 and they would continue to be the
major markets through 2020.

7. Companion Diagnostic Technologies Market Competitive
Analysis & High Level Analysis
Competitive Analysis
A study of some of the key players has showed that majority of the companies in this market are
focusing on collaborations with drug companies. Companion diagnostics is a emerging market and
companies are collaborating with drug companies to develop companion diagnostics for their
pipeline drugs, which are in developing phase. Approvals for companion diagnostics are the second
most popular strategy. Companies profiled in this report include Dako (Agilent Technologies),
Qiagen, Roche, Abbott Laboratories, Inc., Ventana Medical Systems, bioMerieux, Myriad Genetics,
Inc., Resonance Health Ltd., Leica Microsystems, and Life Technologies.
High Level Analysis
The report is focusing on the trends in technology and diagnosis of various indications, which are
driving the growth of the companion diagnostics market. Analysis of the market based on porters
five force model shows that the bargaining power of the suppliers is high as the products produced
are highly differentiated. The threat of new entrants is low as significant research and development
is required for developing diagnostic tests. Apart from the R&D requirements, the investment
required is also high. These factors make it difficult for new companies to enter the market. The
threat of substitutes is low in this market as companion diagnostics are developed for specific
biomarkers and the products are highly differentiated. Competition in this market is moderate as the
market is still emerging and there are a few companies in the market. Government regulations are
favoring use of companion diagnostics for determining a particular treatment.

8. 1. Introduction
2. Executive Summary
3. Market Overview
4. Global Companion Diagnostic Market by Indications
5. Global Companion Diagnostic Market by Technology
6. Global Companion Diagnostic Market by Geography
7. Company Profiles
Table of Contents

9. Global Companion Diagnostic Technologies Market
Overview
Value
Chain
Analysis Companion
Diagnostic
Technologies
Market
Overview
Government
Regulations
Market
Definition and
Scope
Companion
Diagnostics
for Metabolic
Diseases
Companion
diagnostics as
a new trend in
personalized
medicine
Novel trends
&
technologies
in companion
diagnostics
assay
development
Porter’s five
forces
analysis
Key Findings

10. Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market Size
 Market Share
 Market Trends
Opportunities and Forecast
Please inform us on : http://www.alliedmarketresearch.com/contact-us
Market Dynamics
Key Market
Drivers
Market
Restraints
High Cost in
research and
development of
drugs
Market Dynamics
Increase in the
Discovery of
Biomarkers as
drug targets.
Technological
advancements
Increasing
cases of
adverse drug
reactions(ADR)
Increased
popularity of
Personalized
medicine
Economic and
scientific
obstacles
Low price of
competing
technologies

11. Companion Diagnostic Market By Indications
Companion
Diagnostic
Market
By
Indications
Oncology
Others
Inflammation and Auto-
immune diseases
Companion diagnostics in
cardiovascular diseases
Companion diagnostics in
CNS disorders
Companion diagnostics
tests in virology diseases
Others

12. Companion
Diagnostic
Market
By
Technology
Immunohist
ochemistry
Molecular
Diagnostics
Others
Global Companion Diagnostic Market By Technology

13. Top Market Players of Companion Diagnostic Market
 Qiagen
 Dako (Agilent Technologies)
 Roche
 Abbott Laboratories, Inc.
 BioMerieux
 Ventana Medical Systems
 Myriad Genetics, Inc.
 Resonance Health Ltd
 Leica Microsystems
 Life Technologies

14. Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market Size
 Market Share
 Market Trends
Opportunities and Forecast
Please inform us on : http://www.alliedmarketresearch.com/contact-us

15. http://www.alliedmarketresearch.
com/
companion-diagnostic-
technologies-market